Orthopaedic Surgery in Odessa, FL
3 verified orthopaedic surgery doctors in Odessa.
Orthopedic surgeons diagnose and treat conditions of the bones, joints, ligaments, tendons, and muscles.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Malcolm Maclaren, DO
Orthopaedic Surgery
CMS Open Payments· $27.33 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$27.33
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total is on the lower end — around the 41th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Malcolm Maclaren do not imply any wrongdoing. Many are meals, education, or research support.
Dr. James Billys, MD
Orthopaedic Surgery
CMS Open Payments· $319,690 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$319,690
Total received
30
Transactions
11
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to James Billys do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Hugo Keim, MD
Orthopaedic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.